|
summary: The authors investigated the effect of natalizumab, a recently developed treatment for severe relapsing-remitting MS, on the expression of cellular signaling molecules. Most were unaffected except for TNFalpha, which the authors hypothesize may be involved in fatigue.
authors: Khademi M, Stol D, Olsson T, Wallström E.
source: Eur J Neurol. 2008 Mar;15(3):309-12. Epub 2008 Jan 9.
weblink: click here
category: Immunology
related research news: click here
glossary:
Cell
Fatigue
Molecule
Multiple sclerosis
Physical
Relapsing/remitting MS
Sclerosis
Sign
Tumour necrosis
|
